Himadri Speciality Chemical Reports Strong Q2FY26 Profit Growth, Outlines Ambitious Expansion & LiB Strategy
HSCL reports highest-ever Q2FY26 and H1FY26 EBITDA and PAT, despite revenue dip. Outlines aggressive expansion in speciality chemicals, carbon black, and LiB materials, with significant capex and strategic acquisitions.
The announcement details strong financial results, substantial capex for new capacities in speciality carbon black, advanced chemicals, and LFP cathode active materials, and strategic investments in battery technology companies. These initiatives are expected to significantly impact the company's future growth, market share, and long-term profitability, especially in the rapidly expanding EV and energy storage sectors.
The company reported its highest-ever EBITDA and PAT for both the quarter and half-year, demonstrating strong financial performance. This is complemented by ambitious strategic expansion plans, significant capital expenditure in high-growth areas like LiB materials, and key acquisitions that enhance its technological capabilities and market position. The strong focus on sustainability and ESG further adds to the positive outlook.
* Himadri Speciality Chemical Limited (HSCL) announced its investor presentation for the financial results for the quarter and half-year ended 30 September 2025. * Financial Highlights (Standalone - Q2FY26 vs Q2FY25): * Net Revenue from Operations: ₹1,070.41 crore (down 5.71% YoY), primarily due to reduction in raw material prices. * EBITDA: ₹242.71 crore (up 20.54% YoY). * Profit After Tax (PAT): ₹186.85 crore (up 38.98% YoY). * Financial Highlights (Standalone - H1FY26 vs H1FY25): * Net Revenue from Operations: ₹2,170.83 crore (down 7.03% YoY). * EBITDA: ₹476.68 crore (up 22.54% YoY). * Profit After Tax (PAT): ₹369.42 crore (up 43.25% YoY). * The company reported sustained profitability momentum, delivering strong year-on-year EBITDA and PAT growth, recording the highest ever EBITDA & PAT on both quarterly and half-yearly bases. An export order was executed during the quarter, with revenue to be recognized in the next quarter. * Strategic Roadmap & Capex: * FY26: Speciality Carbon Black Expansion (₹220 crore capex) to be completed by Q3FY26 (December 2025). Birla Tyres commencement in Q1FY26 with gradual ramp-up. Launch of branded retail naphthalene balls, Durofresh™. * FY27: Forward integration to produce Anthraquinone and Carbazole (₹120 crore capex) to be completed by Q2FY27 (September 2026). Phase 1 commercial plant for LFP Cathode Active Material (₹1,125 crore capex) to be operational in Q3FY27 (December 2026). * FY28: Full year operations for new capacities and products. * Acquisitions & Investments: * Secured 17.6% equity in Sicona Battery Technologies Pvt. Ltd. with a cumulative investment of ₹103.95 crore, including an exclusive technology licensing partnership for Silicon-Carbon anode technology in India. * Acquired 40% stake in Invati Creations for ₹45.16 crore. * Acquired a 16.24% stake in International Battery Company, Inc. (IBC) for USD 4.43 million (approx. ₹37.47 crore). IBC's Bengaluru Gigafactory is expected by Q4FY27 (March 2027). * New Initiatives: * Successful first export shipment of Liquid Coal Tar Pitch in October 2024. * Aim to produce 2,00,000 MTPA of Lithium Iron Phosphate (LFP) Cathode Active Material, catering to 100 GWh of Li-ion Battery, in phases over the next 5-6 years, positioning as the first commercial plant for LFP Cathode Active Material globally ex-China. * Actively exploring LiB recycling in India, being the only Indian company selected by the Indo German Science and Technology Centre for a landmark battery recycling initiative. * Sustainability & ESG: Achieved EcoVadis Platinum Medal, a 'B' rating in maiden CDP evaluation for Climate Change and Water Security, and various other safety and ESG awards, aligning with Net Zero targets for Scope 1, 2, and 3 emissions. The company also released its TCFD Report for FY 2024-25.
What to do with a filing like this
Himadri Speciality Chemical Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Himadri Speciality Chemical Limited. Read the original for the full detail.